Verve Therapeutics Inc (NASDAQ:VERV) price closed higher on Friday, June 06, and jumping 8.12% above its previous close. A look at the daily price movement shows that the last close reads $5.73. Taking into account the 52-week price action we note that the stock hit
Verve Therapeutics Inc (NASDAQ:VERV) traded at $4.84 at close of the session on Tuesday, June 03 and made an upward move of 0.94% on its previous day’s price. Verve Therapeutics Inc has a market cap of $431.45 million and is expected to release its quarterly
Verve Therapeutics Inc (NASDAQ:VERV) shares, rose in value, with the stock price up by 8.49% to the previous day’s close as strong demand from buyers drove the stock to $4.60. Actively observing the price movement in the last trading, the stock closed the session at
The trading price of Verve Therapeutics Inc (NASDAQ:VERV) closed higher on Friday, May 23, and closing at $4.49, 2.98% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $4.31 and $4.5588. In examining the
Verve Therapeutics Inc (NASDAQ:VERV) price closed higher on Tuesday, May 20, and jumping 5.49% above its previous close. A look at the daily price movement shows that the last close reads $4.37, with intraday deals fluctuated between $4.32 and $4.665. The company’s 5Y monthly beta
Verve Therapeutics Inc (NASDAQ:VERV) price closed lower on current market day and dropping -5.62% below its previous close. A look at the daily price movement shows that the last close reads $4.63. Taking into account the 52-week price action we note that the stock hit
Verve Therapeutics Inc (NASDAQ:VERV) concluded the trading at $4.32 on current market day with a rise of 0.23% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $4.31 and 5Y monthly beta
Verve Therapeutics Inc (NASDAQ:VERV) traded at $4.23 at close of the session on Friday, May 09 and made a downward move of -5.58% on its previous day’s price. Verve Therapeutics Inc has a market cap of $377.06 million and is expected to release its quarterly
Verve Therapeutics Inc (NASDAQ:VERV) price on Wednesday, April 30, rose 3.85% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.67. A look at the stock’s price movement, the close in the last trading session was $5.46, moving
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.